CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8477 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-15

Study Completion Date

2021-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. Identifying these patients and identifying adherence "trajectories" over time would help mobilize human and telemedicine resources on the patients most in need.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern

NCT03987425

Normotensive Obstructive Sleep Apnea

COMPLETED NA

Masked Hypertensive Patients With Obstructive Sleep Apnea

NCT04251975

Obstructive Sleep Apnea Masked Hypertension

COMPLETED NA

Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP

NCT05960175

OSA

RECRUITING NA

Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients

NCT02517346

Sleep Apnea Syndrome

COMPLETED NA

Compliance With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome

NCT03776084

Sleep Apnea, Obstructive

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with the corresponding weeks during 2019.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The study population

Patients meeting eligibility criteria (see appropriate section).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient treated/monitored by the Adene group
* treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or cardio-metabolic/respiratory comorbidities) associated with symptoms from among sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido disorders, nocturia, choking or suffocation during sleep, daytime tiredness)
* Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019
* continuous PAP during 2019
* continuous PAP during 2020
* acceptance of PAP telemonitoring with consent given for data collection and data anonymization